JP Morgan Maintains Overweight on BeiGene, Raises Price Target to $235
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Jessica Fye maintains an Overweight rating on BeiGene (NASDAQ:BGNE) and raises the price target from $200 to $235.

October 22, 2024 | 4:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan has increased its price target for BeiGene from $200 to $235 while maintaining an Overweight rating, indicating confidence in the company's future performance.
The increase in price target from $200 to $235 by JP Morgan suggests a positive outlook on BeiGene's future performance. The maintained Overweight rating indicates continued confidence in the stock, likely leading to a positive short-term impact on its price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100